NEURIDAN

Serial Number 98505482
730

Registration Progress

Application Filed
Apr 17, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jan 07, 2026 155 days

Trademark Image

NEURIDAN

Basic Information

Serial Number
98505482
Filing Date
April 17, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jun 20, 2025
Application
Pending
Classes
005

Rights Holder

NeuroEnergy Ventures, Inc.

03
Address
641 Lexington Avenue
14th Fl
New York, NY 10022

Ownership History

NeuroEnergy Ventures, Inc.

Original Applicant
03
New York, NY

NeuroEnergy Ventures, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Jon Deppe

USPTO Deadlines

Next Deadline
155 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026

Application History

19 events
Date Code Type Description Documents
Jun 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 20, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 20, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 20, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 22, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 22, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 31, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 31, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 31, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 31, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 31, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical agents affecting metabolism; pharmaceutical preparations and substances for treatment of neurological and metabolic-related diseases and disorders; ketone ester beverages for use as dietary supplements and medical foods; dietetic foods adapted for medical purposes; homogenized food adapted for medical purposes; dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes

Additional Information

Translation
The wording NEURIDAN has no meaning in a foreign language.

Classification

International Classes
005